GLP-1 weight-loss medication could slow aging and extend lifespan | Scientific American
A new study finds that semaglutide, a GLP‑1 medication sold as Wegovy or Ozempic, extended lifespan by about 12 percent in aging mice and outperformed calorie restriction in maintaining memory and blood sugar control, suggesting the drug may deliver longevity benefits without dietary hardship.